Modern treatment strategy of gastroduodenal ulcer bleeding

The problem of acute gastroduodenal hemorrhages remains one of the most urgent and unsolved tasks of urgent surgery
Our study included 199 patients with hemorrhage from chronic ulcers. The first group (control) consist 104 patients with hemorrhage of chronic ulcers, in which active tactics was used, based on forecast of rebleeding.
The second group (basic) consist 95 patients with hemorrhage of chronic ulcers, which treated with endoscopic and drug hemostasis; operation was performed only in the case of rebleeding.
Surgical activity in control group was 45,2% (47 patients). Postoperative death was 8,5% (4 patients). Conservative treatment undergone 57 patients (54,8%). Rebleeding occur in two patients (1,9%). Common death rate in first group was 10,5% (11 patients).
In basic group rebleeding occur in 3 patients (3,2%), they all were operated. Postoperative rate death was 40% (2 patients). The Death rate in conservative treatment was 1,1% (1 patient). Common death was 3,2% (3 patients).
Thus the use of endoscopic hemostasis and conservative treatment in patients with hemorrhage from the chronic ulcers, reduce quantities of operations, and decrease the percentage of rebleeding with a reliable decrease in the rate of death.

ulcer gastroduodenal hemorrhages, endoscopic hemostasis